The investment ecosystem is once again revisiting a familiar conversation: funding outcomes for women founders.
The language has evolved in recent years, with words like “pipeline”, “unconscious bias” and “diversity upside” having their day, but the conclusion is usually believed to be the same. Progress is slow, but improving.
The data suggests otherwise.
Women‑only founding teams still receive just two per cent of total startup capital.
Teams with at least one female founder receive around a quarter, leaving the overwhelming majority of funding concentrated in all‑male teams. Deal participation is less skewed – women are involved in roughly a quarter of deals- but women‑only teams account for a small minority of transactions.
These figures are not anecdotal. They come from the State of Australian Startup Funding Report, released in February 2026 by Cut Through Venture and Folklore Ventures. The report shows that while teams with at least one female founder captured 24 per cent of total capital, all‑female founding teams received just two per cent, a figure that has barely shifted over time and is highly concentrated in a small number of large raises.
For long‑term investors, this is not a social statistic. It is a capital allocation signal, and it warrants the same scrutiny applied to any persistent concentration of risk or missed opportunity.
Capital allocation shapes which innovations survive
Where capital flows determines which ideas get tested, which businesses survive early attrition, and which ultimately scale. When a narrow subset of founders receives most early‑stage funding, the immediate effect is fewer ventures being financed. The more consequential effect is that fewer ventures receive sufficient runway to reach the technical, commercial and operational milestones required by later‑stage capital.
Early under‑allocation narrows the pool of companies that survive long enough to become investable at scale.
In practice, this functions as an attrition mechanism. Smaller early cheques slow hiring, delay validation and weaken follow‑on fundraising narratives. By the time companies reach Series A or beyond, differences in capital access are often misread as differences in execution quality. What later appears as a “pipeline problem” is frequently manufactured upstream.
Innovation exits early, not because it fails, but because it is never given adequate time or capital to be properly tested.
What gets screened out, and when
My interest in this issue is not theoretical. While completing an executive MBA, I analysed venture capital allocation data alongside professional experience across academia, agriculture and investment.
In academia, women’s participation, while far from perfect, was comparatively normalised. In agriculture, the picture was also more balanced than many assume, largely because women work alongside men on family farms, contributing directly to operations, decision‑making and innovation, even when their roles are not always formally recognised.
Investment settings looked markedly different.
I observed capable women being spoken over in meetings, ignored in pitch rooms in favour of men who were not part of the founding team, or treated as peripheral to their own businesses. The contrast was striking: in sectors like agriculture, women’s capability is embedded in daily practice and productivity; in investment, credibility is too often filtered through pattern recognition before ideas are properly tested.
That perspective is sharpened by my own position in the system. I work in funds management, actively involved in allocating capital – and I am also a female founder. Much of my motivation for entering funds management came from what I had already seen. Those experiences made clear that capital markets are not neutral arenas. They are shaped by who is heard, who is validated, and who is assumed to be credible before the numbers are even considered.
This raises a harder question: how much credible innovation is lost not because it lacks merit, but because capital is withheld too early?
Why this matters now
That question matters because the sources of future economic advantage are changing.
Productivity, resilience and decarbonisation are increasingly driven by technology‑led solutions, many of which are capital-intensive and slow to mature. In sectors such as energy, water and waste, technologies often require substantial capital early and long development cycles before they become bankable. These are also the sectors where Australia’s long‑term competitiveness will be won or lost.
Yet the funding pattern is familiar. Analysis of the same dataset by Women’s Agenda, alongside coverage by SmartCompanyand Startup Daily, shows that women and mixed‑gender teams are well represented at pre‑seed and seed stages, then drop sharply at Series A and beyond.
This “leaky pipeline” is not explained by performance. Globally, the pattern is consistent. Data from PitchBook’s Female Founders Dashboard, as well as research from Boston Consulting Group, and the Harvard Kennedy School all show that women‑led startups consistently outperform on capital efficiency, generating more revenue per dollar invested despite receiving a disproportionately small share of venture funding.
The issue is not founder quality. It is capital sequencing.
Asset‑heavy, long‑horizon innovation sits uneasily with short‑pacing funding models. When early‑stage capital is already scarce, selective allocation compounds the problem. Teams that enter later, with smaller cheques, are far less likely to survive the extended development cycles required for first‑of‑a‑kind technologies.
The missing middle and who falls into it
The result is not simply fewer venture successes, but fewer credible shots on goal in sectors central to Australia’s future.
Seen this way, the gender funding gap is not just a participation issue. It is an innovation throughput problem.
The State of Australian Startup Funding data shows that since 2019, all‑female founding teams have secured only a handful of large follow‑on rounds. Many credible ventures stall in the “missing middle” between early validation and institutional‑scale capital. When early under‑allocation intersects with long development timelines, exclusion compounds.
The outcome is a narrower pool of scalable companies than the underlying innovation base would otherwise support and at precisely the moment Australia needs more industrial innovation, not less.
This is not about lowering standards or distorting markets. Proven tools already exist. Co‑investment and anchor capital can change the risk calculus without changing the quality threshold, enabling institutional capital to participate in longer‑duration innovation that would otherwise fall outside conventional mandates.
What is missing is accountability.
Those of us working in investment, early‑stage finance and innovation ecosystems are not passive observers. We sit on investment committees, shape mandates, influence underwriting frameworks and decide which risks are worth backing. That includes venture capital firms, funds managers, angel investors, accelerators and the institutions that back them.
International Women’s Day is an opportunity to move beyond statements of intent and ask harder questions. If two per cent persists, it is not because the data is unclear. It is because outcomes are not being interrogated.
International Women’s Day asks us to Balance the Scales – and in early‑stage investing, that means transparency, targets and consequences: publish the numbers, interrogate the underwriting, and change what gets funded.